Scott Thomas Jackson
CIK 1566617 · Chief Executive Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$272.2K
Companies
5
Total Filings
40
Lifetime Open-Market Net
$57.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGNX | Director | 14,750 | $3.96 | $58.4K | $0 | 12 | 2026-05-20 |
| MURAV | Director | — | — | — | $0 | 5 | 2025-12-05 |
| SPRO | Director | 75,000 | $2.85 | $213.8K | $0 | 7 | 2025-06-16 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 5,250 | $15.70 | $82.4K | $0 | 7 | 2024-05-01 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | Chief Executive Officer | 0 | — | — | $57.6K | 8 | 2016-07-12 |
Recent Filings · Page 4 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-25 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2016-07-12 | Celator Pharmaceuticals Inc (CPXX) Delisted | Disp (D) | −301,518 | -$9.12M | EDGAR |
| 2016-07-07 | Celator Pharmaceuticals Inc (CPXX) Delisted | Exer (M) | +251,475 | $714.1K | EDGAR |
| 2016-01-29 | Celator Pharmaceuticals Inc (CPXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-07 | Celator Pharmaceuticals Inc (CPXX) Delisted | Buy (P) | +14,450 | $25.1K | EDGAR |
| 2015-02-27 | Celator Pharmaceuticals Inc (CPXX) Delisted | Grant (A) | +22,593 | $0 | EDGAR |
| 2014-11-18 | Celator Pharmaceuticals Inc (CPXX) Delisted | Buy (P) | +10,000 | $22.0K | EDGAR |
| 2014-02-20 | Celator Pharmaceuticals Inc (CPXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-17 | Celator Pharmaceuticals Inc (CPXX) Delisted | Buy (P) | +3,000 | $10.5K | EDGAR |
| 2013-08-27 | — | Grant (A) | — | $0 |
Showing 31–40 of 40
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.